-
1Academic Journal
Authors: O. S. Groznova, D. A. Kharlamov, S. B. Artemyeva, G. E. Rudenskaya, T. A. Adyan, O. P. Ryzhkova, О. С. Грознова, Д. А. Харламов, С. Б. Артемьева, Г. Е. Руденская, Т. А. Адян, О. П. Рыжкова
Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 1 (2014); 66-70 ; Российский вестник перинатологии и педиатрии; Том 59, № 1 (2014); 66-70 ; 2500-2228 ; 1027-4065 ; undefined
Subject Terms: лечение, X-linked Emery—Dreifuss myopathy, emerin gene, clinical symptoms, cardiomyopathy, atriomegaly, cardiac rhythm disturbances, cardiac conduction disturbance, pacemaker, treatment, прогрессирующая мышечная дистрофия Эмери—Дрейфуса Х-сцепленная, ген эмерин, клинические симптомы, кардиомиопатия, атриомегалия, нарушение ритма сердца, нарушение проводимости сердца, электрокардиостимулятор
File Description: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/36/67; Astejada M.N., Goto K., Nagano A. et al. Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol 2007; 26: 3: 159—164.; Грознова О.С., Новиков П.В., Белозеров Ю.М. и др. Диагностка и тактика лечения поражения сердца при аутосомно-доминантной прогрессирующей мышечной дистрофии Эмери-Дрейфуса. Рос вестн перинатол и педиат 2007; 3; 42—47. (Groznova O.S., Novikov P.V., Belozerov Ju.M., Rudenskaja G.E., Tverskaja S.A. Cardiac lesion in Emery-Dreifus autosome-dominant progressive musculad dystrophy: treatment and policy. Ros vestn perinatol i pediat 2007; 3; 42—47.); Puckelwartz M., McNally E.M. Emery–Dreifuss muscular dystrophy. Handb Clin Neurol 2011; 101: 155—166.; Perrot A., Spuler S., Geier C. et al. Cardiac manifestations of muscular dystrophies. Z Kardiol 2005; 94: 5: 312—320.; Finsterer J., Stöllberger C. Primary myopathies and the heart. Scand Cardiovasc J 2008; 42: 1: 9—24.; Wożakowska-Kapłon B., Bąkowski D. Atrial paralysis due to progression of cardiac disease in a patient with Emery– Dreifuss muscular dystrophy. Cardiol J 2011; 18: 2: 189—193.; Грознова О.С., Новиков П.В. Ранняя диагностика поражения сердца при Х-сцепленной форме мышечной дистрофии Эмери–Дрейфусса у детей. Рос вестн перинатол и педиат 2011; 1; 27—32. (Groznova O.S., Novikov P.V. Early diagnosis of cardiac lesion in X-linked Emery-Dreifus muscular dystrophy in children. Ros vestn perinatol i pediat 2011; 1; 27—32.); Cestan R., LeJonne N.I. Une myopathie avec retractions familiales. Nouv. Iconogr Salpetr 1902; 15: 38—52.; Emery A.E.H. X-linked muscular dystrophy with early contractures and cardiomyopathy (Emery–Dreifuss type). Clin Genet 1987; 32: 360—367.; Yates J.R.W., Warner J.P., Smith J.A. et al. Emery–Dreifuss muscular dystrophy: linkage to markers in distal Xq28. J Med Genet 1993; 30: 108—111.; Bonne G., Leturcq F., Ben Yaou R. Emery–Dreifuss Muscular Dystrophy. R.A. Pagon, T.D. Bird, C.R. Dolan et. al. (Eds). Source GeneReviews™ [Internet]. Seattle (WA): University of Washington. Seattle 2013; 427.; Carboni N., Mura M., Mercuri E. et al. Cardiac and muscle imaging findings in a family with X-linked Emery–Dreifuss muscular dystrophy. Neuromuscul Disord 2012; 22: 2: 152—158.; Finsterer J., Stöllberger C., Keller H. Arrhythmia-related workup in hereditary myopathies. J Electrocardiol 2012; 45: 4: 376—384.; Parmar M.S., Parmar K.S. Emery–Dreifuss humeroperoneal muscular dystrophy: cardiac manifestations. Can J Cardiol 2012; 28: 4: 516. e1—3.; Nigro G., Russo V., Ventriglia V.M. et al. Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery–Dreifuss muscular dystrophy. Neuromuscul Disord 2010; 20: 3: 174—177.; Ishikawa K., Mimuro M., Tanaka T. Ventricular arrhythmia in X-linked Emery–Dreifuss muscular dystrophy: a lesson from an autopsy case. Intern Med 2011; 50: 5: 459—462.; Zaim S., Bach J., Michaels J. Sudden death in an Emery– Dreifuss muscular dystrophy patient with an implantable defibrillator. Am J Phys Med Rehabil 2008; 87: 4: 325—329.; Golzio P.G., Chiribiri A., Gaita F. Unexpected sudden death avoided by implantable cardioverter defibrillator in Emery Dreifuss patient. Europace 2007; 9: 12: 1158—1160.; Buckley A.E., Dean J., Mahy I.R. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 1999; 82: 1: 105—108.; Dickey R.P., Ziter F.A., Smith R.A. Emery–Dreifuss muscular dystrophy. J Pediat 1984; 104: 4: 555—559.; Russo V., Rago A., Palladino A. et al. P-wave duration and dispersion in patients with Emery–Dreifuss muscular dystrophy. J Investig Med 2011; 59: 7: 1151—1154.; Russo V., Rago A., Politano L. et al. Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients. Med Sci Monit 2012; 18: 11: 643—647.; Грознова О.С., Чечуро В.В. Лечение кардиомиопатии у больных прогрессирующими мышечными дистрофиями. Рос вестн перинатол и педиат 2011; 2; 58—62. (Groznova O.S., Chechuro V.V. Treatment for cardiomyopathies in patients with progressive muscular dystrophies. Ros vestn perinatol i pediat 2011; 2; 58—62.); undefined
Availability: https://www.ped-perinatology.ru/jour/article/view/36
-
2Academic Journal
Authors: E. N. Arkhipova, Е. Н. Архипова
Source: Neuromuscular Diseases; Том 5, № 4 (2015); 10-15 ; Нервно-мышечные болезни; Том 5, № 4 (2015); 10-15 ; 2413-0443 ; 2222-8721 ; 10.17650/2222-8721-2015-5-4
Subject Terms: внезапная кардиальная смерть, Duchenne muscular dystrophy, myotonic dystrophy type 1, limb-girdle muscular dystrophy, Emery–Dreifuss muscular dystrophy, dilated cardiomyopathy, ventricular arrhythmias, atrial fibrillations, atrioventricular conduction abnormalities, intraventricular conduction abnormalities, sudden cardiac death, мышечная дистрофия Дюшенна, миотоническая дистрофия 1-го и 2-го типов, поясно-конечностная мышечная дистрофия, мышечная дистрофия Эмери–Дрейфуса, дилатационная кардиомиопатия, желудочковая аритмия, фибрилляция предсердия, нарушение атриовентрикулярной проводимости, нарушение внутрижелудочковой проводимости
Time: 2
File Description: application/pdf
Relation: https://nmb.abvpress.ru/jour/article/view/127/122; Barp A., Bello L., Politano L. et al. Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy. PLoS One 2015;10(10):1–14.; Ferlini A., Sewry C., Melis M.A. et al. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 1999;9:339–46.; Jefferies J.L., Eidem B.W., Belmont J.W. et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005;112:2799–804.; Manzur A.Y., Muntoni F. Diagnosis and new treatments in muscular dystrophies. J Neurol Neurosurg Psychiatry 2009;80: 706–14.; Lodi R., Hart P.E., Rajagopalan B. et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia. Ann Neurol 2001;49(5):590–6.; Holaska J.M. Emerin and the nuclear lamina in muscle and cardiac disease. Circ Res 2008;103:16–23.; English K.M., Gibbs J.L. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol 2006;48:231–5.; Babuty D., Fauchier L., Tena-Carbi D. et al. It is possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods? Heartt 1999;82:634–7.; Bhakta D., Lowe M.R., Groh W.J. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 2004;147:224–7.; Melacini P., Buja G., Fasoli G. et al. The natural history of cardiac involvement in myotonic dystrophy: an eight-year followup in 17 patients. Clin Cardiol 1988; 11:231–8.; Stollberger C., Winkler-Dworak M., Blazek G., Finsterer J. Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation/non-compaction. Cardiology 2007;107:374–9.; Mertens L., Ganame J., Claus P. et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr 2008;21:1049–54.; Silva M.C., Meira Z.M., Gurgel Giannetti J. et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007;49:1874–9.; Kazanegra R., Cheng V., Garcia A. et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 2001;7(1):21–9.; Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart fealure. Task force for the diagnosis and treatment of chronic heart fealure, European Society of cardiology. Eur Heart J 2001;22(17):1527–60.; Verhaert D., Richards K., Rafael-Fortney J.A. Cardiac involvement in patients with muscular dystrophies. Magnetic imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 2011;4(1):67–76.; Архипова Е.Н., Родионова Т.В., Басаргина Е.Н. и др. Закономерности изменения содержания NT-proBNP в крови и их диагностическая значимость у детей с хронической сердечной недостаточностью. Вопросы диагностики в педиатрии. 2012;4(3):11–6. [Аrkhipovа Е.N., Rodionovа Т.V., Basargina Е.N. et al. Common factors of the change of NT-proBNP content in blood and its diagnostic value at children with chronic cardiac failure. Voprosy diagnostiki v pediatrii = Diagnostic Issues in Pediatrics 2012;4(3):11–6. (In Russ.)].; Ishikawa K. Cardiac involvement in progressive muscular dystrophy of the Duchenne type. Jpn Heart J 1997;38:163–80.; Thrush P.T., Allen H.D., Viollet L., Mendell J.R. Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy. Am J Cardiol 2009;103:262–5.; Kirchmann C., Kececioglu D., Korinthenberg R., Dittrich S. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol 2005;26:66–72.; Klitzner T.S., Beekman R., Galioto F.M. et al. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005;116: 1569–73.; Muntoni F. Cardiac complications of childhood myopathies. J Child Neurol 2003;18:191–202.; Bunse M., Bit-Avragim N., Riefflin A. et al. Cardiac energetics correlates to myocardial hypertrophy in Friedreich’s ataxia. Ann Neurol 2003;53(1):121–3.; Finsterer J., Stollberger C. Neuromuscular disorders associated with apical hypertrophic cardiomyopathy. Acta Cardiol 2009;64:85–9.; Басаргина Е.Н., Архипова Е.Н., Жарова О.П. Типичные ошибки при лечении хронической сердечной недостаточности со сниженной систолической функцией у детей. Фарматека 2014;(1): 55–62. [Basargina E.N., Arkhipova E.N., Zharova O.P. Typical errors in the treatment of chronic cardiac failure with diminished systolic function in children. Farmateka = Pharmatec 2014;(1):55–62. (In Russ.)].; Connuck D.M., Sleeper L.A., Colan S.D. et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008;155:998–1005.; Duboc D., Meune C., Pierre B. et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ followup. Am Heart J 2007;154: 596–602.; Rhodes J., Margossian R., Darras B.T. et al. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol 2008;29:343–51.; https://nmb.abvpress.ru/jour/article/view/127
-
3Academic Journal
Authors: МИРОНОВИЧ СЕРГЕЙ АЛЕКСАНДРОВИЧ, ШЕСТАК АННА ГЕННАДЬЕВНА, ПОДОЛЯК ДМИТРИЙ ГЕННАДЬЕВИЧ, ЗАКЛЯЗЬМИНСКАЯ ЕЛЕНА ВАЛЕРЬЕВНА, ДЗЕМЕШКЕВИЧ СЕРГЕЙ ЛЕОНИДОВИЧ
File Description: text/html
-
4Academic Journal
Source: Патология кровообращения и кардиохирургия.
File Description: text/html
